To the best of my knowledge, P2(Pellegrino 2) was to provide an indication of the current and future valuation of the POET technlogy, especially in terms of the many vertical markets it will affect. This valuation should also consider the numerous patents and other IP generated to date.

P2 will provide a potential "starting point" for a price in the event of a potential purchase of some or all of Dr. Taylor's and his team's work.

P1 was Iissued in 2011 and put POET's value at about $5/share, well before the current milestones were achieved.

On a personal note, I cannot even imagine what this new evaluation will be, considering how far reaching and pervasive this company's innovations will be. IMHO, I think Poet is priceless...